Université Catholique de Louvain (UCL)

Core-Level Binding Energies from GW: An Efficient Full-Frequency Approach within a Localized Basis (2018) Golze D, Wilhelm J, Van Setten MJ, Rinke P Journal article Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia (2018) Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, Van Der Flier WM, et al. Journal article Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial (2018) Ignatiadis M, Litiere S, Rothe F, Riethdorf S, Proudhon C, Fehma T, Aalders K, et al. Journal article Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study (2018) Van Der Heijde D, Durez P, Schett G, Naredo E, Ostergaard M, Meszaros G, De Leonardis F, et al. Journal article International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (2018) Pages F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, et al. Journal article Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency (2017) Lovric S, Goncalves S, Gee HY, Oskouian B, Srinivas H, Choi WI, Shril S, et al. Journal article Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients (2017) Gross S, Erdmann M, Haendle I, Voland S, Berger T, Schultz E, Strasser E, et al. Journal article STRUCTURAL DAMAGE PROGRESSION IN PATIENTS TREATED WITH METHOTREXATE, BARICITINIB MONOTHERAPY OR BARICITINIB plus METHOTREXATE BASED ON THEIR LEVEL OF CLINICAL RESPONSE IN THE PHASE 3 RA-BEGIN STUDY (2017) Van Der Heijde D, Durez P, Schett G, Naredo E, Ostergaard M, Meszaros G, Bello N, et al. Conference contribution Exploratory Analysis to Identify Factors Associated with Risk of Structural Progression, Defined As Change from Baseline (2017) Van Der Heijde D, Durez P, Schett G, Naredo E, Ostergaard M, Meszaros G, Lopez-Romero P, et al. Conference contribution STAG1 mutations cause a novel cohesinopathy characterised by unspecific syndromic intellectual disability (2017) Lehalle D, Mosca-Boidron AL, Begtrup A, Boute-Benejean O, Charles P, Cho MT, Clarkson A, et al. Journal article